Editorial Board Members’ Collection: Cardiovascular Pharmacology and Therapeutics
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 298
Special Issue Editors
Interests: natural products; phytocannabinoids; cannabinoid signalling; neurodegenerative diseases; ischemic heart diseases; cardiometabolic diseases
Interests: G protein-coupled receptors; hypertension; menopause; biosensor development; nitric oxide synthases; signaling via Ca2+ and calmodulin; estrogen and estrogen receptors; cardiovascular biology: endothelial, vascular smooth muscle and myocardial functions; heart failure
Special Issue Information
Dear Colleagues,
We are pleased to announce this collection entitled “Editorial Board Members’ Collection: Cardiovascular Pharmacology and Therapeutics”. This Special Issue will be a collection of papers by researchers invited by the Editorial Board Members. The aim is to provide a venue for networking and communication between scholars in the field of cardiovascular pharmacology and therapeutics. All papers will be fully open access upon publication after peer review.
Dr. Shreesh Kumar Ojha
Dr. Kim Tran
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular pharmacology
- cardiovascular medicine
- cardiovascular pathobiology
- therapies for preventive cardiology
- regenerative cardiology
- cardioprotective therapies
- antiarrhythmic therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
